Literature DB >> 19754805

Coarse fractionated radiation therapy for pituitary tumours in cats: a retrospective study of 12 cases.

M J Brearley1, G A Polton, R M Littler, S J M Niessen.   

Abstract

This retrospective study describes the clinical progression of 12 cats with pituitary tumours treated with a coarse fractionated radiation protocol delivering a total dose of 37 Gy in five once weekly fractions. A pituitary macrotumour was identified in all 12 cats: 4 with neurological signs only and 8 with insulin-resistant diabetes mellitus secondary to acromegaly. One of the cats with central neurological signs died before completing the radiotherapy course; the remaining three had partial or complete remissions of their central neurological signs. Of the cats with unstable diabetes mellitus, five no longer required insulin therapy, one required less insulin and two became stable. The overall median survival time was 72.6 weeks; four cats died from related causes, two from unrelated problems and six remain alive. Radiation therapy is confirmed as an effective treatment for feline pituitary tumours, giving prolonged survival and control of both paraneoplastic and mass effect signs.

Entities:  

Year:  2006        PMID: 19754805     DOI: 10.1111/j.1476-5829.2006.00108.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  9 in total

1.  Radiotherapy and pasireotide treatment of a growth hormone producing pituitary tumor in a diabetic dog.

Authors:  Francesco Zublena; Alice Tamborini; Carmel T Mooney; Susan M North; Monika A Lobacz; Dan Andrew; Vanessa Woolhead; Heather Covey; Herbert A Schmid; David B Church; Stijn J M Niessen
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

2.  Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.

Authors:  Stijn J M Niessen; Yaiza Forcada; Panagiotis Mantis; Christopher R Lamb; Norelene Harrington; Rob Fowkes; Márta Korbonits; Ken Smith; David B Church
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

3.  Evaluation and diagnostic potential of serum ghrelin in feline hypersomatotropism and diabetes mellitus.

Authors:  K B Jensen; Y Forcada; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

4.  Stereotactic radiation therapy for the treatment of functional pituitary adenomas associated with feline acromegaly.

Authors:  Tiffany L Wormhoudt; Mary-Keara Boss; Katharine Lunn; Lynn Griffin; Del Leary; Kristy Dowers; Sangeeta Rao; Susan M LaRue
Journal:  J Vet Intern Med       Date:  2018-05-21       Impact factor: 3.333

5.  Successful treatment of feline hyperadrenocorticism with pituitary macroadenoma using radiation therapy: a case study.

Authors:  Naoko Yayoshi; Yuji Hamamoto; Hitomi Oda; Aiko Haga; Kaoru Koyama; Toshinori Sako; Akihiro Mori
Journal:  J Vet Med Sci       Date:  2022-05-05       Impact factor: 1.105

6.  Clinical findings, diagnostic test results, and treatment outcome in cats with spontaneous hyperadrenocorticism: 30 cases.

Authors:  S Y Valentin; C C Cortright; R W Nelson; B M Pressler; D Rosenberg; G E Moore; J C Scott-Moncrieff
Journal:  J Vet Intern Med       Date:  2014-01-16       Impact factor: 3.333

7.  Long-term management and postmortem examination in a diabetic cat with acromegaly treated with two courses of radiation therapy.

Authors:  Harumi Sawada; Akihiro Mori; Masaki Michishita; Hitomi Oda; Toshinori Sako
Journal:  J Vet Med Sci       Date:  2018-11-16       Impact factor: 1.267

8.  Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats.

Authors:  Joe Fenn; Patrick J Kenny; Christopher J Scudder; Katarina Hazuchova; Ruth Gostelow; Robert C Fowkes; Yaiza Forcada; David B Church; Stijn J M Niessen
Journal:  J Vet Intern Med       Date:  2021-02-24       Impact factor: 3.333

9.  Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.

Authors:  Kirsten L van Bokhorst; Sara Galac; Hans S Kooistra; Chiara Valtolina; Federico Fracassi; Dan Rosenberg; Björn P Meij
Journal:  J Vet Intern Med       Date:  2021-02-23       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.